Samuel E. McLinn

1.2k total citations
30 papers, 981 citations indexed

About

Samuel E. McLinn is a scholar working on Epidemiology, Otorhinolaryngology and Microbiology. According to data from OpenAlex, Samuel E. McLinn has authored 30 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 14 papers in Otorhinolaryngology and 14 papers in Microbiology. Recurrent topics in Samuel E. McLinn's work include Pneumonia and Respiratory Infections (19 papers), Ear Surgery and Otitis Media (14 papers) and Bacterial Infections and Vaccines (14 papers). Samuel E. McLinn is often cited by papers focused on Pneumonia and Respiratory Infections (19 papers), Ear Surgery and Otitis Media (14 papers) and Bacterial Infections and Vaccines (14 papers). Samuel E. McLinn collaborates with scholars based in United States, Chile and Czechia. Samuel E. McLinn's co-authors include Michael E. Pichichero, John D. Nelson, Kenneth C. Haltalin, Gerson H. Aronovitz, Ron Dagan, Jesús M Feris, Daniel Burch, Nazha Abughali, M R Jacobs and Eugene Leibovitz and has published in prestigious journals such as JAMA, PEDIATRICS and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Samuel E. McLinn

29 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel E. McLinn United States 21 641 342 311 255 219 30 981
Sharon Shelton United States 15 502 0.8× 178 0.5× 131 0.4× 236 0.9× 278 1.3× 23 888
Lolita Piglansky Israel 17 1.0k 1.6× 351 1.0× 419 1.3× 618 2.4× 70 0.3× 24 1.3k
Christopher J. Harrison United States 17 700 1.1× 194 0.6× 137 0.4× 172 0.7× 111 0.5× 41 1.1k
Alan E. Gober United States 20 427 0.7× 258 0.8× 232 0.7× 116 0.5× 56 0.3× 38 1.0k
Jesús M Feris United States 13 542 0.8× 92 0.3× 70 0.2× 328 1.3× 182 0.8× 21 736
M E Pichichero United States 17 383 0.6× 115 0.3× 84 0.3× 223 0.9× 187 0.9× 23 808
SIMON RAIZ Israel 17 743 1.2× 375 1.1× 515 1.7× 466 1.8× 38 0.2× 22 1.0k
Rimma Melamed Israel 15 932 1.5× 104 0.3× 30 0.1× 513 2.0× 49 0.2× 37 1.2k
M. Derriennic France 8 202 0.3× 110 0.3× 79 0.3× 56 0.2× 45 0.2× 26 342
Austin Sydnor United States 7 341 0.5× 106 0.3× 445 1.4× 59 0.2× 109 0.5× 8 620

Countries citing papers authored by Samuel E. McLinn

Since Specialization
Citations

This map shows the geographic impact of Samuel E. McLinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel E. McLinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel E. McLinn more than expected).

Fields of papers citing papers by Samuel E. McLinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel E. McLinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel E. McLinn. The network helps show where Samuel E. McLinn may publish in the future.

Co-authorship network of co-authors of Samuel E. McLinn

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel E. McLinn. A scholar is included among the top collaborators of Samuel E. McLinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel E. McLinn. Samuel E. McLinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Block, Stan L., Antonio Arrieta, Markus J. Seibel, et al.. (2003). Single-dose (30 mg/kg) azithromycin compared with 10-day amoxicillin/clavulanate for the treatment of uncomplicated acute otitis media: a double-blind, placebo-controlled, randomized clinical trial. Current Therapeutic Research. 64. 30–42. 28 indexed citations
2.
Dagan, Ron, Samuel E. McLinn, Nazha Abughali, et al.. (2000). Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. The Pediatric Infectious Disease Journal. 19(2). 95–104. 150 indexed citations
3.
Block, Stan L., et al.. (1999). SPECTRAL GRADIENT ACOUSTIC REFLECTOMETRY: DETECTION OF MIDDLE EAR EFFUSION IN SUPPURATIVE ACUTE OTITIS MEDIA. The Pediatric Infectious Disease Journal. 18(8). 741–744. 16 indexed citations
4.
Block, Stan L., et al.. (1998). Spectral gradient acoustic reflectometry for the detection of middle ear effusion by pediatricians and parents. The Pediatric Infectious Disease Journal. 17(6). 560–564. 39 indexed citations
5.
Pichichero, Michael E., et al.. (1998). Clinical and Economic Impact of Enterovirus Illness in Private Pediatric Practice. PEDIATRICS. 102(5). 1126–1134. 31 indexed citations
6.
Pichichero, Michael E., Samuel E. McLinn, Gerson H. Aronovitz, et al.. (1997). Cefprozil treatment of persistent and recurrent acute otitis media. The Pediatric Infectious Disease Journal. 16(5). 471–478. 55 indexed citations
7.
McLinn, Samuel E.. (1996). A multicenter, double blind comparison of azithromycin and amoxicillin/clavulanate for the treatment of acute otitis media in children. The Pediatric Infectious Disease Journal. 15(9 Suppl). 20–23. 46 indexed citations
8.
McLinn, Samuel E. & D. Williams. (1996). Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media. The Pediatric Infectious Disease Journal. 15(9 Suppl). 3–9. 27 indexed citations
9.
Blumer, Jeffrey L., et al.. (1995). Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. The Pediatric Infectious Disease Journal. 14(Supplement). S115–120. 19 indexed citations
10.
McLinn, Samuel E., et al.. (1995). Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulate in the empiric treatment of acute otitis media. The Pediatric Infectious Disease Journal. 14(Supplement). S108–114. 20 indexed citations
11.
Hoberman, Alejandro, James McCarty, Samuel E. McLinn, et al.. (1994). Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. The Journal of Pediatrics. 125(1). 136–141. 51 indexed citations
12.
McLinn, Samuel E., Michael J. Moskal, Johanna Goldfarb, et al.. (1994). Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrobial Agents and Chemotherapy. 38(2). 315–318. 33 indexed citations
13.
Mendelman, Paul M., et al.. (1992). Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media. The Journal of Pediatrics. 121(3). 459–465. 40 indexed citations
14.
Pichichero, Michael E., Gerson H. Aronovitz, W M Gooch, et al.. (1990). Comparison of Cefuroxime Axetil, Cefaclor, and Amoxicillin—Clavulanate Potassium Suspensions in Acute Otitis Media in Infants and Children. Southern Medical Journal. 83(10). 1174–1177. 37 indexed citations
15.
McLinn, Samuel E.. (1990). A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo. Journal of the American Academy of Dermatology. 22(5). 883–885. 30 indexed citations
16.
McLinn, Samuel E.. (1988). Topical mupirocin vs. systemic erythromycin treatment for pyoderma. The Pediatric Infectious Disease Journal. 7(11). 789–789. 28 indexed citations
17.
McLinn, Samuel E.. (1987). Randomized, open label, multicenter trial of cefixime compared with amoxicillin for treatment of acute otitis media with effusion. The Pediatric Infectious Disease Journal. 6(10). 997–1001. 35 indexed citations
18.
Lietman, Paul S., et al.. (1982). Double-blind multicenter comparison of cyclacillin and amoxicillin for the treatment of acute otitis media. The Journal of Pediatrics. 101(4). 617–621. 6 indexed citations
19.
McLinn, Samuel E.. (1980). Cefaclor in Treatment of Otitis Media and Pharyngitis in Children. Archives of Pediatrics and Adolescent Medicine. 134(6). 560–560. 33 indexed citations
20.
McLinn, Samuel E., John D. Nelson, & Kenneth C. Haltalin. (1970). ANTIMICROBIAL SUSCEPTIBILITY OF HEMOPHILUS INFLUENZAE. PEDIATRICS. 45(5). 827–838. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon Shelton Breakdown of academic impact, for papers by Lolita Piglansky Breakdown of academic impact, for papers by Christopher J. Harrison Breakdown of academic impact, for papers by Alan E. Gober Breakdown of academic impact, for papers by Jesús M Feris Breakdown of academic impact, for papers by M E Pichichero Breakdown of academic impact, for papers by SIMON RAIZ Breakdown of academic impact, for papers by Rimma Melamed Breakdown of academic impact, for papers by M. Derriennic Breakdown of academic impact, for papers by Austin Sydnor
Rankless by CCL
2026